Finance

Lists
016580:KRX
Whanin Pharm Co Ltd
â‚©9,940.00
-1.49%
(-150.00) 1D
Sep 21, 3:30:12 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 016580...
Open
â‚©10,090
High
â‚©10,090
Low
â‚©9,890
Mkt. cap
184.88B
Avg. vol.
34.96K
Volume
27.74K
Dividend
3.02%
Quarterly dividend
â‚©75
Ex-dividend date
Dec 27, 2023
P/E ratio
8.69
52-wk high
â‚©12,140
52-wk low
â‚©9,160
EPS
â‚©1,143
Shares outstanding
18.60M
No. of employees
631
Open
â‚©10,090
High
â‚©10,090
Low
â‚©9,890
Mkt. cap
184.88B
Avg. vol.
34.96K
Volume
27.74K
Dividend
3.02%
Quarterly dividend
â‚©75
Ex-dividend date
Dec 27, 2023
P/E ratio
8.69
52-wk high
â‚©12,140
52-wk low
â‚©9,160
EPS
â‚©1,143
Shares outstanding
18.60M
No. of employees
631
About Whanin Pharm Co Ltd
CEOWon Beom Lee
Employees631
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
65.74B
65.14B
71.18B
71.42B
Cost of goods sold
44.31B
41.64B
44.93B
43.64B
Cost of revenue
44.31B
41.64B
44.93B
43.64B
Research and development expenses
498.72M
251.09M
173.17M
158.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.48B
20.86B
15.87B
18.59B
Operating expense
17.87B
22.02B
16.87B
19.88B
Total operating expenses
62.18B
63.66B
61.79B
63.52B
Operating income
3.56B
1.48B
9.38B
7.89B
Other non operating income
98.76M
70.26M
-441.28M
20.12M
EBT including unusual items
4.06B
1.73B
9.98B
9.78B
EBT excluding unusual items
4.06B
2.01B
9.97B
9.78B
Income tax expense
785.02M
-281.62M
2.52B
2.08B
Effective tax rate
19.33%
-16.28%
25.20%
21.31%
Other operating expenses
249.44M
322.59M
224.25M
582.58M
Net income
3.28B
2.01B
7.47B
7.70B
Net profit margin
4.98%
3.09%
10.49%
10.78%
Earnings per share
-
-
-
-
Interest and investment income
501.75M
456.44M
1.38B
523.44M
Interest expense
-7.37M
-8.35M
-9.05M
-9.78M
Net interest expenses
494.37M
448.10M
1.37B
513.67M
Depreciation and amortization charges
228.49M
219.37M
218.97M
228.93M
EBITDA
6.03B
3.93B
11.84B
10.35B
Gain or loss from assets sale
-498.00K
282.08M
-14.20M
1.00K
AI content may include mistakes. Learn more
Google apps